1例贝纳柯克斯体椎体骨髓炎患者的药学监护  

Pharmaceutical care of a case with vertebral osteomyelitis of Coxiella burnetiid

作　　者：沈江华[1] 孔超 潘福敏 褚燕琦[1] SHEN Jianghua;KONG Chao;PAN Fumin;CHU Yanqi(Department of Pharmacy,Xuanwu Hospital of Capital Medical University,Beijing 100053,China;Department of Orthopedics,Xuanwu Hospital of Capital Medical University,Beijing 100053,China)

机构地区：[1]首都医科大学宣武医院药剂科,北京100053 [2]首都医科大学宣武医院骨科,北京100053

出　　处：《中国药物警戒》2024年第10期1166-1168,共3页Chinese Journal of Pharmacovigilance

基　　金：首都卫生发展科研专项重点公关项目(首发2024-1-2012)。

摘　　要：目的通过对1例贝纳柯克斯体椎体骨髓炎患者的病例介绍,探讨临床药师开展特殊感染患者的药学监护的切入点及在罕见病原体导致感染患者治疗过程的作用。方法分析临床药师参与1例由贝纳柯克斯体引起腰椎感染患者的治疗过程,协助医生分析患者病史及病原学特点,提出敏感药物治疗方案,并对其持续进行药学监护,协助医生评估治疗效果,并持续调整药物治疗方案。结果及结论临床药师协助医生制定治疗方案,以特殊病原菌引起罕见部位感染为切入点,对患者开展药学监护,保障患者病情稳定好转。临床药师参与治疗团队可有效保障患者用药安全。Objective To explore the starting point where clinical pharmacists can carry out pharmaceutical care for patients with special infections by studying one case of Coxiella burnetii vertebral osteomyelitis.Methods Clinical pharmacists participated in the treatment of one case of lumbar spine infection caused by Coxiella burnetii,assisted clinicians in analyzing the patient’s history and etiology,proposed medications with sensitive drugs,provided sustainable pharmaceutical care for the patient,got involved in evaluating the therapeutic effect,and kept adjusting the drug treatment plans.Results and Conclusion Clinical pharmacists assisted doctors in opting for medications and ensuring stable improvement of the patient’conditions.Clinical pharmacists can do much to ensure the safety of medications by participating in a treatment team and starting with rare site infections caused by special pathogens.

关 键 词：贝纳柯克斯体 Q热立克次体 慢性Q热 椎体骨髓炎 药学监护 

分 类 号：R978[医药卫生—药品] R969.3[医药卫生—药学]